SKI Market

A+| A| A-|

Indian Indices

Sensex

76,264.33 736.38
( 0.97%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

69,318.21 3,298.17
(5.00%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Beryl Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524606

INE415H01017

19.4445649

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

27.4

11.68

EPS(TTM)

Face Value()

Div & Yield %

0.84

Back

Jubilant Pharmova consolidated net profit declines 44.60% in the December 2025 quarter

Feb 06,2026

Net profit of Jubilant Pharmova declined 44.60% to Rs 55.90 crore in the quarter ended December 2025 as against Rs 100.90 crore during the previous quarter ended December 2024. Sales rose 16.67% to Rs 2116.10 crore in the quarter ended December 2025 as against Rs 1813.70 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2116.10	1813.70	17
OPM %	13.68	15.83	-
PBDT	253.80	240.70	5
PBT	133.10	149.40	-11
NP	55.90	100.90	-45

76,264.33 736.38 ( 0.97%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

69,318.21 3,298.17 (5.00%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)